Sunshine Lake Pharma Co., Ltd. (HKG:6887)

Sunshine Lake Pharma Revenue

Sunshine Lake Pharma had revenue of 1.08B CNY in the half year ending June 30, 2026, a decrease of -58.35%. This brings the company's revenue in the last twelve months to 3.95B, up 28.35% year-over-year. In the year 2025, Sunshine Lake Pharma had annual revenue of 4.82B with 19.81% growth.

• Revenue (ttm): 3.95B CNY
• Revenue Growth: +28.35%
• P/S Ratio: 4.61
• Revenue / Employee: 627.51K CNY
• Employees: 6,299
• Market Cap: 21.05B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.82B	796.16M	19.81%
Dec 31, 2024	4.02B	-2.28B	-36.15%
Dec 31, 2023	6.29B	2.55B	68.08%
Dec 31, 2022	3.74B	2.83B	309.83%
Dec 31, 2021	913.79M	-1.43B	-61.08%

Data Source: S&P Global Market Intelligence Last updated: Aug 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 11, 2026

Data Sources Report a data error